SEARCH

SEARCH BY CITATION

References

  • Abuladze, T., Li, M., Menetrez, M.Y., Dean, T., Senecal, A. and Sulakvelidze, A. (2008) Bacteriophages reduce experimental contamination of hard surfaces, tomato, spinach, broccoli, and ground beef by Escherichia coli O157:H7. Appl Environ Microbiol 74, 62306238.
  • Adams, M.H. (1959) Bacteriophages. OCLC 326505. New York: Interscience.
  • Ahmed, R., Bopp, C., Borczyk, A. and Kasatiya, S. (1987) Phage-typing scheme for Escherichia coli O157:H7. J Infect Dis 155, 806809.
  • Ahmed, R., Ali, A., Demczuk, W., Woodward, D., Clark, C., Khakria, R. and Rodgers, F. (2001) Emergence of new molecular and phage typing variants of E. coli O157:H7 in Canada. In Verocytotoxigenic E. coli in Europe. Epidemiology of Verocytotoxigenic E. coli. Concerted Action CT98-3935. Teagasc Vol. 5 ed. Duffy, G., Garvey, P., Coia, J., Wasteson, Y. and McDowell, D.A. p. 123. Dublin: The National Food Centre.
  • Arisaka, F. (2005) Assembly and infection process of bacteriophage T4. Chaos 15, 7502(1)7502(7).
  • Bach, S.J., Selinger, L.J., Stanford, K. and McAllister, T.A. (2005) Effect of supplementing corn- or barley-based feedlot diets with canola oil on faecal shedding of Escherichia coli O157:H7 by steers. J Appl Microbiol 98, 464475.
  • Biswas, B., Adhya, S., Washart, P., Paul, B., Trostel, A.N., Powell, B., Carlton, R. and Merril, C.R. (2002) Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect Immun 70, 204210.
  • Brüssow, H. (2005) Phage therapy: the Escherichia coli experience. Microbiology 151, 21332140.
  • Callaway, T.R., Edrington, T.S., Brabban, A.D., Anderson, R.C., Rossman, M.L., Engler, M.J., Carr, M.A., Genovese, K.J. et al. (2008) Bacteriophage isolated from feedlot cattle can reduce Escherichia coli O157:H7 populations in ruminant gastrointestinal tracts. Foodborne Pathog Dis 5, 183191.
  • Capparelli, R., Ventimiglia, I., Roperto, S., Fenizia, D. and Iannelli, D. (2006) Selection of an Escherichia coli O157:H7 bacteriophage for persistence in the circulatory system of mice infected experimentally. Clin Microbiol Infect 12, 248253.
  • Capparelli, R., Parlato, M., Borriello, G., Salvatore, P. and Iannelli, D. (2007) Experimental phage therapy against Staphylococcus aureus in mice. Antimicrob Agents Chemother 51, 27652773.
  • Carlton, R.M., Noordman, W.H., Biswas, B., De Meester, E.D. and Loessner, M.J. (2005) Bacteriophage P100 for control of Listeria monocytogenes in foods: genome sequence, bioinformatic analyses, oral toxicity study, and application. Regulat Toxicol Pharmacol 43, 301312.
  • Carroll, A.M., Gibson, A. and McNamara, E.B. (2005) Laboratory-based surveillance of human verocytotoxigenic Escherichia coli infection in the republic of Ireland, 2002–2004. J Med Microbiol 54, 11631169.
  • Elder, R.O., Keen, J.E., Siragusa, G.R., Barkocy-Gallagher, G.A., Koohmaraie, M. and Laegreid, W.W. (2000) Correlation of enterohemorrhagic Escherichia coli O157 prevalence in feces, hides, and carcasses of beef cattle during processing. Proc Natl Acad Sci USA 97, 29993003.
  • Frost, J.A., Smith, H.R., Willshaw, G.A., Scotland, S.M., Gross, R.J. and Rowe, B. (1989) Phage-typing of Vero-cytotoxin (VT) producing Escherichia coli O157 isolated in the United Kingdom. Epidemiol Infect 103, 7381.
  • Gannon, V.P., D’Souza, S., Graham, T. and King, R.K. (1997) Specific identification of Escherichia coli O157:H7 using multiplex PCR assay. Adv Exp Med Biol 412, 8182.
  • Greer, G.G. (2005) Bacteriophage control of foodborne bacteria. J Food Prot 68, 11021111.
  • Guth, B.E.C., Chinen, I., Miliwebsky, E., Cerqueira, A.M.F., Chillemi, G., Andrade, J.R.C., Baschkier, A. and Rivas, M. (2003) Serotypes and Shiga toxin genotypes among Escherichia coli isolated from animals and food in Argentina and Brazil. Vet Microbiol 92, 335349.
  • Heller, K.J. (1992) Molecular interaction between bacteriophage and the gram-negative cell envelope. Arch Microbiol 158, 235248.
  • Heller, K.J. and Bryniok, D. (1984) O-antigen-dependent mutant of bacteriophage T5. J Virol 49, 2025.
  • Iguchi, A., Iyoda, S., Watanabe, H. and Osawa, R. (2007) O side chain deficiency enhances sensitivity of Escherichia coli to Shiga toxin 2-converting bacteriophages. Curr Microbiol 54, 1419.
  • Inoue, T., Matsuzaki, S. and Tanaka, S. (1995a) A 26-kDa outer membrane protein, OmpK, common to Vibrio species is the receptor for a broad-host-range vibriophage, KVP40. FEMS Microbiol Lett 125, 101106.
  • Inoue, T., Matsuzaki, S. and Tanaka, S. (1995b) Cloning and sequence analysis of Vibrio parahaemolyticus ompK gene encoding a 26-kDa outer membrane protein, OmpK, that serves as receptor for a broad-host-range vibriophage, KVP40. FEMS Microbiol Lett 134, 245249.
  • Jones, J.B., Jackson, L.E., Balogh, B., Obradovic, A., Iriarte, F.B. and Momol, M.T. (2007) Bacteriophages for plant disease control. Annu Rev Phytopathol 45, 245262.
  • Khakhria, R., Duck, D. and Lior, H. (1990) Extended phage-typing scheme for Escherichia coli O157:H7. Epidemiol Infect 105, 511520.
  • Kudva, I.T., Jelacic, S., Tarr, P.I., Youderian, P. and Hovde, C.J. (1999) Biocontrol of Escherichia coli O157 with O157-specific bacteriophages. Appl Environ Microbiol 65, 37673773.
  • Leotta, G.A., Miliwebsky, E.S., Chinen, I., Espinosa, E.M., Azzopardi, K., Tennant, S.M., Robins-Browne, R.M. and Rivas, M. (2008) Characterisation of Shiga toxin-producing Escherichia coli O157 strains isolated from humans in Argentina, Australia and New Zealand. BMC Microbiol 8, 4653.
  • Merril, C.R., Scholl, D. and Adhya, S. (2006) Phage Therapy. In The Bacteriophages ed. Calendar, R. pp. 725739. New York, NY: Oxford University Press.
  • Mizoguchi, K., Morita, M., Fischer, C.R., Yoichi, M., Tanji, Y. and Unno, H. (2003) Coevolution of bacteriophage PP01 and Escherichia coli O157:H7 in continuous culture. Appl Environ Microbiol 69, 170176.
  • Mora, A., Blanco, M., Blanco, J.E., Alonso, M.P., Dhabi, G., Thomson-Carter, F., Usera, M.A., Bartolomé, R. et al. (2004) Phage types and genotypes of Shiga toxin-producing Escherichia coli O157:H7 isolates from humans and animals in Spain: identification and characterization of two predominating phage types (PT2 and PT8). J Clin Microbiol 42, 40074015.
  • Mora, A., León, S.L., Blanco, M., Blanco, J.E., López, C., Dahbi, G., Echeita, A., González, E.A. et al. (2007) Phage types, virulence genes and PFGE profiles of Shiga toxin-producing Escherichia coli O157:H7 isolated from raw beef, soft cheese and vegetables in Lima (Peru). Int J Food Microbiol 114, 204210.
  • Morita, M., Fischer, C.R., Mizoguchi, K., Yoichi, M., Oda, M., Tanji, Y. and Unno, H. (2002) Amino acid alterations in Gp38 of host range mutants of PP01 and evidence for their infection of an ompC null mutant of Escherichia coli O157:H7. FEMS Microbiol Lett 216, 243248.
  • Nastasijevic, I., Mitrovic, R. and Buncic, S. (2007) Occurrence of Escherichia coli O157 on hides of slaughtered cattle. Lett Appl Microbiol 46, 126131.
  • Nishikawa, Y., Hase, A., Ogasawara, J., Cheasty, T., Willshaw, G.A., Smith, H.R., Tatsumi, Y. and Yasukawa, A. (2001) Phage typing and DNA-based comparison of strains of enterohemorrhagic Escherichia coli O157 from apparently sporadic infections in Osaka city, Japan, 1996. Jpn J Infect Dis 54, 140143.
  • Niu, Y.D., Xu, Y., McAllsiter, T.A., Rozema, E.A., Stephens, T.P., Bach, S.J., Johnson, R.P. and Stanford, K. (2008) Comparison of fecal versus rectoanal mucosal swab sampling for detecting Escherichia coli O157:H7 in experimentally inoculated cattle used in assessing bacteriophage as a mitigation strategy. J Food Prot 71, 691698.
  • Oporto, B., Esteban, J.I., Aduriz, G., Juste, R.A. and Hurtado, A. (2008) Escherichia coli O157:H7 and non-O157 Shiga toxin-producing E. coli in healthy cattle, sheep and swine herds in northern Spain. Zoonoses Publ Health 55, 7381.
  • Perry, M.B., Maclean, L. and Griffith, D.W. (1986) Structure of the O-chain polysaccharide of the phenol-phase soluble lipopolysaccharide of Escherichia coli O157:H7. Biochem Cell Biol 64, 2128.
  • Rangel, J.M., Sparling, P.H., Crowe, C., Griffin, P.M. and Swerdlow, D.L. (2005) Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982–2002. Emerg Infect Dis 11, 603609.
  • Rozema, E.A., Stephens, T.P., Bach, S.J., Okine, E.K., Johnson, R.P., Stanford, K. and McAllister, T.A. (2009) Oral and rectal administration of bacteriophages for control of Escherichia coli O157:H7 in feedlot cattle. J Food Protect 72, 241250.
  • Sambrook, J. and Russell, D.W. (2001) Molecular Cloning: A Laboratory Manual, 3rd edn. Cold Spring Harbor, New York, NY: Cold Spring Harbor Laboratory Press.
  • Santander, J. and Robeson, J. (2007) Phage-resistance of Salmonella enterica serovar Enteritidis and pathogenesis in Caenorhabditis elegans is mediated by the lipopolysaccharide. Electron J Biotechnol 10, 627632.
  • Scholl, D., Rogers, S., Adhya, S. and Merril, C.R. (2001) Bacteriophage K1–5 encodes two different tail fiber proteins, allowing it to infect and replicate on both K1 and K5 strains of Escherichia coli. J Virol 75, 25092515.
  • Serna, A. and Boedeker, E.C. (2008) Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections. Curr Opin Gastroenterol 24, 3847.
  • Sharma, R.S., Mishra, V., Mohmmed, A. and Babu, C.R. (2008) Phage specificity and lipopolysaccarides of stem- and root-nodulating bacteria (Azorhizobium caulinodans, Sinorhizobium spp., and Rhizobium spp.) of Sesbania spp. Arch Microbiol 189, 411418.
  • Skurnik, M., Pajunen, M. and Kilkunen, S. (2007) Biotechnological challenges of phage therapy. Biotechnol Lett 29, 9951003.
  • Smith, H.W. and Huggins, H.B. (1982) Successful treatment of experimental Escherichia coli in mice using phages: its general superiority over antibiotics. J Gen Microbiol 128, 307318.
  • Stanford, K., Croy, D., Bach, S.J., Wallins, G.L., Zahiroddini, H. and McAllister, T.A. (2005) Ecology of Escherichia coli O157:H7 in commercial dairies in Southern Alberta. J Dairy Sci 88, 44414451.
  • Sulakvelidze, A., Alavidze, Z. and Morris, J.G. Jr (2001) Bacteriophage therapy. Antimicrob Agents Chemother 45, 649659.
  • Tanji, Y., Shimada, T., Fukudomi, H., Miyanaga, K., Nakai, Y. and Unno, H. (2005) Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice. J Biosci Bioeng 100, 280287.
  • Tarr, P.I., Gordon, C.A. and Chandler, W.L. (2005) Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365, 10731086.
  • Viscardi, M., Perugini, G.A., Auriemma, C., Capuano, F., Morabito, S., Kim, K.P., Loessner, J.M. and Iovane, G. (2008) Isolation and characterisation of two novel coliphages with high potential to control antibiotic-resistant pathogenic Escherichia coli (EHEC and EPEC). Int J Antimicrob Agents 31, 152157.
  • Waddell, T., Mazzocco, A., Johnson, R., Pacan, J., Campbell, S., Perets, A., MacKinnon, J., Holtslander, B. et al. (2000) Control of Escherichia coli O157:H7 infection of calves by bacteriophages. In Fourth International Symposium and Workshop on Shiga toxin (verocytotoxin)-producing Escherichia coli (VTEC 2000), Kyoto, Japan.
  • Watanabe, R., Matsumoto, T., Sano, G., Ishii, Y., Tateda, K., Sumiyama, Y., Uchiyama, J., Sakurai, S. et al. (2007) Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice. Antimicrob Agents Chemother 51, 446452.
  • Weinbauer, M.G. (2004) Ecology of prokaryotic viruses. FEMS Microbiol Rev 28, 127181.
  • Wichels, A., Biel, S.S., Gelderblom, H.R., Brinkhoff, T., Muyzer, G. and Schütt, C. (1998) Bacteriophage diversity in the North Sea. Appl Environ Microbiol 64, 41284133.
  • Woodward, D.L., Clark, C.G., Caldeira, R.A., Ahmed, R. and Rodgers, F.G. (2002) Verotoxigenic Escherichia coli (VTEC): a major public health threat in Canada. Can J Infect Dis 13, 321330.
  • Yoichi, M., Morita, M., Mizoguchi, K., Fischer, C.R., Unno, H. and Tanji, Y. (2004) The criterion for selecting effective phage for Escherichia coli O157:H7 control. Biochem Eng J 19, 221227.